Literature DB >> 27559759

Vital Signs: Epidemiology of Sepsis: Prevalence of Health Care Factors and Opportunities for Prevention.

Shannon A Novosad, Mathew R P Sapiano, Cheri Grigg, Jason Lake, Misha Robyn, Ghinwa Dumyati, Christina Felsen, Debra Blog, Elizabeth Dufort, Shelley Zansky, Kathryn Wiedeman, Lacey Avery, Raymund B Dantes, John A Jernigan, Shelley S Magill, Anthony Fiore, Lauren Epstein.   

Abstract

BACKGROUND: Sepsis is a serious and often fatal clinical syndrome, resulting from infection. Information on patient demographics, risk factors, and infections leading to sepsis is needed to integrate comprehensive sepsis prevention, early recognition, and treatment strategies.
METHODS: To describe characteristics of patients with sepsis, CDC and partners conducted a retrospective chart review in four New York hospitals. Random samples of medical records from adult and pediatric patients with administrative codes for severe sepsis or septic shock were reviewed.
RESULTS: Medical records of 246 adults and 79 children (aged birth to 17 years) were reviewed. Overall, 72% of patients had a health care factor during the 30 days before sepsis admission or a selected chronic condition likely to require frequent medical care. Pneumonia was the most common infection leading to sepsis. The most common pathogens isolated from blood cultures were Escherichia coli in adults aged ≥18 years, Klebsiella spp. in children aged ≥1 year, and Enterococcus spp. in infants aged <1 year; for 106 (33%) patients, no pathogen was isolated. Eighty-two (25%) patients with sepsis died, including 65 (26%) adults and 17 (22%) infants and children.
CONCLUSIONS: Infection prevention strategies (e.g., vaccination, reducing transmission of pathogens in health care environments, and appropriate management of chronic diseases) are likely to have a substantial impact on reducing sepsis. CDC, in partnership with organizations representing clinicians, patients, and other stakeholders, is launching a comprehensive campaign to demonstrate that prevention of infections that cause sepsis, and early recognition of sepsis, are integral to overall patient safety.

Entities:  

Mesh:

Year:  2016        PMID: 27559759     DOI: 10.15585/mmwr.mm6533e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  48 in total

1.  Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients.

Authors:  Deborah Stefanova; Antoan Raychev; Jaime Deville; Romney Humphries; Shelley Campeau; Piotr Ruchala; Elizabeta Nemeth; Tomas Ganz; Yonca Bulut
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

2.  Healthcare Utilization and Infection in the Week Prior to Sepsis Hospitalization.

Authors:  Vincent X Liu; Gabriel J Escobar; Rakesh Chaudhary; Hallie C Prescott
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

3.  Nephroprotective strategies in septic shock: the VANISH trial.

Authors:  Sophia Kwon; George Crowley; Syed Hissam Haider; Liqun Zhang; Anna Nolan
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Pneumonia-Associated Hospitalizations, New York City, 2001-2014.

Authors:  Christopher H Gu; David E Lucero; Chaorui C Huang; Demetre Daskalakis; Jay K Varma; Neil M Vora
Journal:  Public Health Rep       Date:  2018 Sep/Oct       Impact factor: 2.792

5.  Combatting Sepsis: A Public Health Perspective.

Authors:  Raymund B Dantes; Lauren Epstein
Journal:  Clin Infect Dis       Date:  2018-09-28       Impact factor: 9.079

6.  Outpatient beta-blockers and survival from sepsis: Results from a national cohort of Medicare beneficiaries.

Authors:  Kathleen E Singer; Courtney E Collins; Julie M Flahive; Allison S Wyman; M Didem Ayturk; Heena P Santry
Journal:  Am J Surg       Date:  2017-06-24       Impact factor: 2.565

7.  Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure.

Authors:  James Baggs; John A Jernigan; Alison Laufer Halpin; Lauren Epstein; Kelly M Hatfield; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

8.  Platelet reactivity in sepsis syndrome: results from the PRESS study.

Authors:  Karolina Akinosoglou; Spyridoula Theodoraki; Ioanna Xanthopoulou; Angelos Perperis; Theologia Gkavogianni; Aikaterini Pistiki; Evangelos Giamarellos-Bourboulis; Charalambos A Gogos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-24       Impact factor: 3.267

9.  Trends in methicillin-resistant Staphylococcus aureus bloodstream infections using statewide population-based surveillance and hospital discharge data, Connecticut, 2010-2018.

Authors:  Ashley N Rose; Paula Clogher; Kelly M Hatfield; Runa H Gokhale; Isaac See; Susan Petit
Journal:  Infect Control Hosp Epidemiol       Date:  2020-06       Impact factor: 3.254

Review 10.  Emerging Technologies for Molecular Diagnosis of Sepsis.

Authors:  Mridu Sinha; Julietta Jupe; Hannah Mack; Todd P Coleman; Shelley M Lawrence; Stephanie I Fraley
Journal:  Clin Microbiol Rev       Date:  2018-02-28       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.